Harilal V. Patel
Clinical R&D
Ahmedabad, UP, India
Ahmedabad, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar rats.
Journal: The Journal of antimicrobial chemotherapy
Published: October 07, 2025
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats.
Journal: Chemico-biological interactions
Published: August 29, 2025
Preclinical safety, tolerability and pharmacokinetics of a novel cyclobenzaprine hydrochloride nasal spray.
Journal: Regulatory toxicology and pharmacology : RTP
Published: February 06, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease.
Journal: Experimental neurology
Published: December 13, 2024
Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia.
Journal: Frontiers in nephrology
Published: July 04, 2024
Safety Assessment of a Novel Intravenous Diclofenac Sodium Formulation Following 28-Day Repeated Administration in Wistar Rats.
Journal: International journal of toxicology
Published: June 20, 2024
Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: May 21, 2024
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 29, 2023
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY-IL1 in Three Patients with Cryopyrin-Associated Periodic Syndromes.
Journal: Clinical pharmacology in drug development
Published: June 29, 2023
Pharmacokinetics and Safety Evaluation of Single-Dose Saroglitazar Magnesium in Subjects with Hepatic Impairment.
Journal: Clinical pharmacology in drug development
Published: March 08, 2023
Last Updated: 09/26/2026